loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 21303 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE (6)

filter

01 TAKEDA PHARMS USA (6)

filter

01 CAPSULE, EXTENDED RELEASE;ORAL (6)

filter

01 1.25MG;1.25MG;1.25MG;1.25MG (1)

02 2.5MG;2.5MG;2.5MG;2.5MG (1)

03 3.75MG;3.75MG;3.75MG;3.75MG (1)

04 5MG;5MG;5MG;5MG (1)

05 6.25MG;6.25MG;6.25MG;6.25MG (1)

06 7.5MG;7.5MG;7.5MG;7.5MG (1)

filter

01 USA (6)

URL Supplier Web Content
CAPSULE, EXTENDED RELE...
5MG;5MG;5MG;5MG
ADDERALL XR 20
USA
21303
2001-10-11
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
1.25MG;1.25MG;1.25MG;1...
ADDERALL XR 5
USA
21303
2002-05-22
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
7.5MG;7.5MG;7.5MG;7.5M...
ADDERALL XR 30
USA
21303
2001-10-11
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
2.5MG;2.5MG;2.5MG;2.5M...
ADDERALL XR 10
USA
21303
2001-10-11
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
3.75MG;3.75MG;3.75MG;3...
ADDERALL XR 15
USA
21303
2002-05-22
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, EXTENDED RELE...
6.25MG;6.25MG;6.25MG;6...
ADDERALL XR 25
USA
21303
2002-05-22
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21303

Looking for CTD TGA MCC DOSSIER APPLICATION 21303 6

19

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 21303 and regulatory information .

proudly manufactured in the

approval since 2001-10-11

Takeda Pharmaceutical's ADDERALL XR 20 CAPSULE, EXTENDED RELEASE;ORAL, medication with 5MG;5MG;5MG;5MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

18

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 21303 and regulatory information .

proudly manufactured in the

approval since 2002-05-22

Takeda Pharmaceutical's ADDERALL XR 5 CAPSULE, EXTENDED RELEASE;ORAL, medication with 1.25MG;1.25MG;1.25MG;1.25MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

17

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 21303 and regulatory information .

proudly manufactured in the

approval since 2001-10-11

Takeda Pharmaceutical's ADDERALL XR 30 CAPSULE, EXTENDED RELEASE;ORAL, medication with 7.5MG;7.5MG;7.5MG;7.5MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

16

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 21303 and regulatory information .

proudly manufactured in the

approval since 2001-10-11

Takeda Pharmaceutical's ADDERALL XR 10 CAPSULE, EXTENDED RELEASE;ORAL, medication with 2.5MG;2.5MG;2.5MG;2.5MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

15

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 21303 and regulatory information .

proudly manufactured in the

approval since 2002-05-22

Takeda Pharmaceutical's ADDERALL XR 15 CAPSULE, EXTENDED RELEASE;ORAL, medication with 3.75MG;3.75MG;3.75MG;3.75MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

14

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE, with a corresponding application number 21303 and regulatory information .

proudly manufactured in the

approval since 2002-05-22

Takeda Pharmaceutical's ADDERALL XR 25 CAPSULE, EXTENDED RELEASE;ORAL, medication with 6.25MG;6.25MG;6.25MG;6.25MG of AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE.

Post Enquiry
POST ENQUIRY